Apotheca Biosciences, Inc. engages in the development of cutting-edge medical products, nutraceuticals, formulation and delivery technologies for the healthcare and consumer care industries. Its products include transdermal, sublingual, and nasal delivery technologies for precise and controlled dosing of cannabinoids. The company was founded on October 6, 2014 and is headquartered in St. Petersburg, FL.